NANOPHTHALMIC UVEAL EFFUSION MANAGED WITH SCLERAL WINDOWS AND TOPICALMITOMYCIN-C

The authors treated a 38-year-old man with nanophthalmic uveal effusio n with scleral windows and local application of mitomycin-C. The patie nt underwent two separate surgical procedures, involving placement of scleral windows in all four quadrants and topical application of mitom ycin-C in one quadrant. Episcleral scarring led to closure of scleral windows in all quadrants except one quadrant where mitomycin-C was app lied during the first surgery. The uveal effusion resolved following t he second surgery. No complications related to mitomycin-C were observ ed. Topical mitomycin-C may be a useful adjunct in the surgical manage ment of uveal effusion syndrome.